Extramedullary disease in Waldenström macroglobulinemia: A population‐based observational study
Our findings indicate a persistent risk of EMD throughout the disease course, with no significant impact on long-term survival.
Authors
- Simon Østergaard (ORCID: https://orcid.org/0009-0003-3845-1878)
- Lars Møller Pedersen (ORCID: https://orcid.org/0000-0002-9419-8841)
- Torsten Holm Nielsen (ORCID: https://orcid.org/0009-0000-7309-3859)
- Lise Mette Rahbek Gjerdrum (ORCID: https://orcid.org/0000-0003-4377-3209)
- Mette Ølgod Pedersen (ORCID: https://orcid.org/0000-0002-8561-9421)
- Lars Munksgaard (ORCID: https://orcid.org/0009-0007-5553-7269)
- Troels Hammer
Institutions
- University of Copenhagen (DK)
- Danish Medicines Agency (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- Zealand University Hospital (DK)
Publication Details
- Journal
- eJHaem
- Published
- 2024-10-25
- DOI
- https://doi.org/10.1002/jha2.1037
- Citations
- 2
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.88
Funders
- Region Sjælland